Return On Assets of BioXcel Therapeutics, Inc. from 30 Sep 2018 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
BioXcel Therapeutics, Inc. quarterly and annual Return On Assets in % history and change rate from 30 Sep 2018 to 30 Sep 2025.
  • BioXcel Therapeutics, Inc. Return On Assets for the quarter ending 30 Sep 2025 was -185%, a 76% decline year-over-year.
  • BioXcel Therapeutics, Inc. annual Return On Assets for 2024 was -101%, a 30% increase from 2023.
  • BioXcel Therapeutics, Inc. annual Return On Assets for 2023 was -145%, a 99% decline from 2022.
  • BioXcel Therapeutics, Inc. annual Return On Assets for 2022 was -73%, a 67% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

BioXcel Therapeutics, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -185% -80% -76% 01 Jul 2025 30 Sep 2025
Q2 2025 -134% -0.46% -0.34% 01 Apr 2025 30 Jun 2025
Q1 2025 -84% +71% +46% 01 Jan 2025 31 Mar 2025
Q4 2024 -101% +43% +30% 01 Oct 2024 31 Dec 2024
Q3 2024 -105% +30% +22% 01 Jul 2024 30 Sep 2024
Q2 2024 -134% -29% -27% 01 Apr 2024 30 Jun 2024
Q1 2024 -154% -69% -81% 01 Jan 2024 31 Mar 2024
Q4 2023 -145% -72% -99% 01 Oct 2023 31 Dec 2023
Q3 2023 -135% -77% -132% 01 Jul 2023 30 Sep 2023
Q2 2023 -105% -54% -107% 01 Apr 2023 30 Jun 2023
Q1 2023 -85% -40% -89% 01 Jan 2023 31 Mar 2023
Q4 2022 -73% -29% -67% 01 Oct 2022 31 Dec 2022
Q3 2022 -58% -16% -37% 01 Jul 2022 30 Sep 2022
Q2 2022 -51% -8.4% -20% 01 Apr 2022 30 Jun 2022
Q1 2022 -45% +6.2% +12% 01 Jan 2022 31 Mar 2022
Q4 2021 -44% +9.9% +19% 01 Oct 2021 31 Dec 2021
Q3 2021 -42% +22% +34% 01 Jul 2021 30 Sep 2021
Q2 2021 -42% +48% +53% 01 Apr 2021 30 Jun 2021
Q1 2021 -51% +30% +37% 01 Jan 2021 31 Mar 2021
Q4 2020 -53% +32% +37% 01 Oct 2020 31 Dec 2020
Q3 2020 -64% +14% +18% 01 Jul 2020 30 Sep 2020
Q2 2020 -91% -24% -36% 01 Apr 2020 30 Jun 2020
Q1 2020 -81% -33% -68% 01 Jan 2020 31 Mar 2020
Q4 2019 -85% -46% -120% 01 Oct 2019 31 Dec 2019
Q3 2019 -79% -41% -109% 01 Jul 2019 30 Sep 2019
Q2 2019 -67% 01 Apr 2019 30 Jun 2019
Q1 2019 -49% 01 Jan 2019 31 Mar 2019
Q4 2018 -39% 01 Oct 2018 31 Dec 2018
Q3 2018 -38% 01 Jul 2018 30 Sep 2018

BioXcel Therapeutics, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -101% +43% +30% 01 Jan 2024 31 Dec 2024
2023 -145% -72% -99% 01 Jan 2023 31 Dec 2023
2022 -73% -29% -67% 01 Jan 2022 31 Dec 2022
2021 -44% +9.9% +19% 01 Jan 2021 31 Dec 2021
2020 -53% +32% +37% 01 Jan 2020 31 Dec 2020
2019 -85% -46% -120% 01 Jan 2019 31 Dec 2019
2018 -39% 01 Jan 2018 31 Dec 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.